Wesley S. Lobo - 01 Sep 2021 Form 4 Insider Report for NEPHROS INC (NEPH)

Role: Chief Commercial Officer
Signature: /s/ Christopher Melsha as attorney-in-fact for Wesley Lobo pursuant to Power of Attorney previously filed.
Issuer symbol: NEPH
Transactions as of: 01 Sep 2021
Net transactions value: $0
Form type: 4
Filing time: 03 Sep 2021, 16:29:07 UTC
Previous filing: 23 Aug 2021
Next filing: 18 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NEPH	Common Stock						41,557	01 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEPH	Stock Option (right to buy)	Award	$0	+57,368		$0.000000	57,368	01 Sep 2021	Common Stock	57,368	$8.47	Direct	F3
holding	NEPH	Stock Optoin (right to buy)						114,178	01 Sep 2021	Common Stock	114,178	$8.66	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes (i) 20,557 shares of restricted stock for which the risk of forfeiture will lapse on 2/16/22; and (ii) 20,000 shares of restricted stock for which the risk of forfeiture will lapse as to 5,000 shares on each of 2/16/22, 2/16/23, 2/16/24 and 2/16/25.
F2	Options to purchase 28,545 shares vest on 2/16/22 and options to purchase 85,633 shares vest quarterly in 12 equal amounts commencing on 5/16/22.
F3	Options to purchase 14,342 shares vest on 9/1/22 and options to purchase 43,026 shares vest quarterly in 12 equal amounts commencing on 12/1/22.